Telehealth and Telecare News since 2005 ...

27 June 2025. TTA will be on hiatus due to a ‘break’. Literal, and not a vacation! Articles and Alerts will resume at a date TBD in July. No, this shouldn’t happen to you–an unwanted hiatus for Editor ...

A company most have never heard of is snapping up provider networks, health plans, and management services. Astrana Health, a Southern California-based value-based care (VBC) company formerly known as ...

Transcarent closes Accolade buy, changes its game. Transcarent’s $621 million acquisition of Accolade was wrapped up in record time (two months from announcement). This takes the Nasdaq-listed ...

In news other than Walgreens and Optum/Change Healthcare–with more to come out of HIMSS in Orlando this week… The DOD/VA Cerner EHR went live on Saturday 9 March in the Capt. James A. Lovell Federal ...

Omada Health plans exit into the public markets. Omada, which has virtual health diabetes and hypertension management programs, reportedly filed an S-1 with the Securities and Exchange Commission (SEC ...

Barely a week later, but only a few buyers are lining up for 23andMe’s parts. The future of the bits and pieces of 23andMe and their 15 million customers apparently are in the Magic 8 Ball’s response ...

VA moving forward with the 2026 Oracle Cerner rollout of (lucky?) 13 centers. In March, the Department of Veterans Affairs (VA) announced that the EHR Modernization (EHRM) for 2026 would be expanded ...

The waning days of summer wrapped with a few moderate-sized fundings: India’s Qure.AI scored a $65 million Series D, bringing their total funding to $125 million. Leading the raise: Lightspeed and 360 ...

The Department of Veterans Affairs (VA) pulls on the parking brake for Oracle Cerner, but doesn’t turn off the engine. Last Friday (21 April), the VA formally announced ) that it would cease further ...

Oracle Cerner EHR rollout faces yet another hurdle. The Department of Veterans Affairs (VA) announced that the next go-live, Ann Arbor (Michigan) Healthcare System, originally scheduled for completion ...

Walgreens was too big to fail entirely–but made too many mistakes and remained in too many dying segments. The Gimlet Eye credits Walgreens for making a good deal with private equity firm Sycamore ...